News
19h
showsnob.com on MSNJune definitely needs to be in The Testaments (but not right away)That’s not surprising when you consider The Testaments is happening, and it’s a sequel to the original series. The Handmaid’s ...
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
On Wednesday 13th September, pharmaphorum headed to London’s Wellcome Collection for Gilead’s book launch of “From the Margins”, a unique and impactful publication that brings together in ...
1d
MedPage Today on MSNNovel Agent Succeeds in Tough-to-Treat Invasive Fungal DiseaseMaertens reported relationships with F2G, Cidara, Pfizer, Gilead, MSD, Takeda, Mundipharma, Basilea, and Shionogi. Co-authors ...
Gilead Sciences, Inc., a biopharmaceutical company ... and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies.
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
Deadline’s It Starts on the Page (Drama) features standout drama series scripts in 2025 Emmy contention. Hulu’s The ...
WWI pandemic is explored in The Flu That Killed 50 Million, Murder 24/7 returns for a new run, there's the New Zealand ...
At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...
Western Mass. writer and editor Jennifer Acker zeroed in on her top five epistolary books and it ended up being published in ...
2d
IFLScience on MSNRevolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA ApprovalThe breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results